Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.
- DOI
- 10.1038/s41392-025-02567-3
- Published
- 2026 Feb 11
- Container
- Signal transduction and targeted therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41392-025-02567-3,
title = {Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.},
author = {Zhang Y and Tang S and Chen L and Song S and Cao J and Tian G and Xiao G and Shen J and Zhang L},
year = {2026},
journal = {Signal transduction and targeted therapy},
doi = {10.1038/s41392-025-02567-3},
url = {https://doi.org/10.1038/s41392-025-02567-3}
}RIS
TY - JOUR TI - Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus. AU - Zhang Y AU - Tang S AU - Chen L AU - Song S AU - Cao J AU - Tian G AU - Xiao G AU - Shen J AU - Zhang L PY - 2026 JO - Signal transduction and targeted therapy DO - 10.1038/s41392-025-02567-3 UR - https://doi.org/10.1038/s41392-025-02567-3 ER -
APA
Y, Z., S, T., L, C., S, S., J, C., G, T., G, X., J, S., & L, Z. (2026). Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-025-02567-3
Source records
- pubmed · retrieved 2026-09-25T23:49:09.402Z